Updates
** Shares of medical device maker Abbott ABT.N rise 5.4% to $133.05
** ABT is the top performer on the S&P 500 .SPX index on Wednesday
** Stock has its best day since April 2023, if gains hold
** ABT, in a conference call, says it doesn't expect any tariff impact in Q2
** Impact of tariffs is projected to be a few hundred million dollars in 2025 - company
** ABT reaffirms its annual profit per share forecast of between $5.05 and $5.25, but beats Q1 earnings estimate
** Company says two new manufacturing and R&D investments in Illinois and Texas, totaling $500 million, are projected to go live by the end of 2025
** Up to last close, stock up 11.6% YTD
(Reporting by Sriparna Roy and Puyaan Singh in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.